Literature DB >> 6325170

Transcriptional regulation of a herpes simplex virus immediate early gene is mediated through an enhancer-type sequence.

J C Lang, D A Spandidos, N M Wilkie.   

Abstract

An enhancer-type sequence has been identified in the promoter region for the herpes simplex virus type 1 (HSV-1) immediate early (IE) mRNA 3. The enhancer-type activity is host cell dependent, being greater in human cells and Syrian hamster cells (the usual host cell for in vitro propagation of HSV) than in Chinese hamster or mouse cells. Enhancer activity is stimulated up to 10-fold after superinfection by tsK, a temperature-sensitive mutant of HSV-1. The induction of enhancer activity is independent of de novo protein synthesis, showing that trans-activation is effected by a component of the virion. We propose that trans-regulation of IE mRNA 3 is mediated through an enhancer-type sequence, and that this provides one explanation for previously described regulation of HSV IE mRNAs by virion components.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6325170      PMCID: PMC557355          DOI: 10.1002/j.1460-2075.1984.tb01817.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  58 in total

1.  Inverted repetitions in the chromosome of herpes simplex virus.

Authors:  P Sheldrick; N Berthelot
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1975

2.  Transfer of the gene for thymidine kinase to thymidine kinase-deficient human cells by purified herpes simplex viral DNA.

Authors:  S Bacchetti; F L Graham
Journal:  Proc Natl Acad Sci U S A       Date:  1977-04       Impact factor: 11.205

3.  Control of protein synthesis in herpesvirus-infected cells: analysis of the polypeptides induced by wild type and sixteen temperature-sensitive mutants of HSV strain 17.

Authors:  H S Marsden; I K Crombie; J H Subak-Sharpe
Journal:  J Gen Virol       Date:  1976-06       Impact factor: 3.891

4.  Sequence arrangement in herpes simplex virus type 1 DNA: identification of terminal fragments in restriction endonuclease digests and evidence for inversions in redundant and unique sequences.

Authors:  N M Wilkie; R Cortini
Journal:  J Virol       Date:  1976-10       Impact factor: 5.103

5.  Biochemical studies on the herpes simplex virus-specified deoxypyrimidine kinase activity.

Authors:  A T Jamieson; J H Subak-Sharpe
Journal:  J Gen Virol       Date:  1974-09       Impact factor: 3.891

6.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

7.  Anatomy of herpes simplex virus DNA: evidence for four populations of molecules that differ in the relative orientations of their long and short components.

Authors:  G S Hayward; R J Jacob; S C Wadsworth; B Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  1975-11       Impact factor: 11.205

8.  Rat insulin genes: construction of plasmids containing the coding sequences.

Authors:  A Ullrich; J Shine; J Chirgwin; R Pictet; E Tischer; W J Rutter; H M Goodman
Journal:  Science       Date:  1977-06-17       Impact factor: 47.728

9.  An improved technique for obtaining enhanced infectivity with herpes simplex virus type 1 DNA.

Authors:  N D Stow; N M Wilkie
Journal:  J Gen Virol       Date:  1976-12       Impact factor: 3.891

10.  Expression and regulation of immunoglobulin heavy chain gene transfected into lymphoid cells.

Authors:  M S Neuberger
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

View more
  41 in total

1.  Association of ICP0 but not ICP27 with purified virions of herpes simplex virus type 1.

Authors:  F Yao; R J Courtney
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

2.  DNA binding by the herpes simplex virus type 1 ICP4 protein is necessary for efficient down regulation of the ICP0 promoter.

Authors:  J Resnick; B A Boyd; M L Haffey
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

3.  Overlapping octamer and TAATGARAT motifs in the VF65-response elements in herpes simplex virus immediate-early promoters represent independent binding sites for cellular nuclear factor III.

Authors:  C M apRhys; D M Ciufo; E A O'Neill; T J Kelly; G S Hayward
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

4.  Construction and characterization of a herpes simplex virus type 1 mutant unable to transinduce immediate-early gene expression.

Authors:  C I Ace; T A McKee; J M Ryan; J M Cameron; C M Preston
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

5.  Expression of a cellular gene cloned in herpes simplex virus: rabbit beta-globin is regulated as an early viral gene in infected fibroblasts.

Authors:  J R Smiley; C Smibert; R D Everett
Journal:  J Virol       Date:  1987-08       Impact factor: 5.103

6.  Herpes simplex virus immediate-early promoters are responsive to virus and cell trans-acting factors.

Authors:  I H Gelman; S Silverstein
Journal:  J Virol       Date:  1987-07       Impact factor: 5.103

7.  Dissection of immediate-early gene promoters from herpes simplex virus: sequences that respond to the virus transcriptional activators.

Authors:  I H Gelman; S Silverstein
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

8.  Direct correlation between a negative autoregulatory response element at the cap site of the herpes simplex virus type 1 IE175 (alpha 4) promoter and a specific binding site for the IE175 (ICP4) protein.

Authors:  M S Roberts; A Boundy; P O'Hare; M C Pizzorno; D M Ciufo; G S Hayward
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

9.  Association of herpes simplex virus regulatory protein ICP4 with sequences spanning the ICP4 gene transcription initiation site.

Authors:  S W Faber; K W Wilcox
Journal:  Nucleic Acids Res       Date:  1988-01-25       Impact factor: 16.971

10.  Cells that constitutively express the herpes simplex virus immediate-early protein ICP4 allow efficient activation of viral delayed-early genes in trans.

Authors:  R H Persson; S Bacchetti; J R Smiley
Journal:  J Virol       Date:  1985-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.